🇺🇸 FDA
Pipeline program

ADSC01

CMUH110-REC1-042

Phase 2 mab active

Quick answer

ADSC01 for Connective Tissue Diseases is a Phase 2 program (mab) at Xiyuan Hospital of China Academy of Chinese Medical Sciences with 1 ClinicalTrials.gov record(s).

Program details

Company
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Indication
Connective Tissue Diseases
Phase
Phase 2
Modality
mab
Status
active

Clinical trials